Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and dermatology, diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Revenue projections:

Revenue projections for TORNTPHARM
Revenue projections for TORNTPHARM

Torrent Pharmaceuticals Limited's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.

Financial Ratios:

currentRatio 1.396000
forwardPE 41.999935
debtToEquity 33.400000
earningsGrowth 0.305000
revenueGrowth 0.143000
grossMargins 0.756870
operatingMargins 0.266200
trailingEps 63.290000
forwardEps 0.000000

With a current ratio of 1.396, TORNTPHARM has the liquidity needed to easily service its short-term debt. The company's cash reserves and current assets are sufficient, indicating that TORNTPHARM is in a strong position to meet its immediate financial obligations without difficulty.
Positive earnings and revenue growth for TORNTPHARM point to expected business expansion. The company is projected to continue growing its operations, as increasing profits and sales highlight a strong trajectory for further growth in the future.
With positive gross and operating margins, Torrent Pharmaceuticals Limited demonstrates strong profitability. This reflects the company's ability to manage costs and maintain healthy profits, showcasing effective operational efficiency and financial stability.

Price projections:

Price projections for TORNTPHARM
Price projections for TORNTPHARM

The steady upward revision of TORNTPHARM's price projections indicates growing confidence in the company's performance. Analysts are becoming increasingly optimistic about TORNTPHARM's future prospects and potential for growth.

Recommendation changes over time:

Recommendations trend for TORNTPHARM
Recommendations trend for TORNTPHARM


Analysts' buy bias for Torrent Pharmaceuticals Limited signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to Torrent Pharmaceuticals Limited, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.